|
|
|
|
| Symbol(s): |
WST |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
WST has a current Overall Rating of C (Neutral). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| WST has a current Overall Rating of C (Neutral). Appreciation potential (55) is neutral; Power Rating (40) is neutral. Relative to the S&P 500 Composite, West Pharmaceutical Svsc Inc has moderate Growth characteristics -- its appeal is likely to be to investors neutral towards Income. WST is of very low investment quality. Current annual total return performance of 41.1% is upper quartile. Current 5-year total return performance of 4.2% is slightly below median. Over the full time...
| | |
|
|
